TickerFacts.

Warby Parker Inc. (WRBY): Cash & Equivalents

Annual figures by period end, from SEC filings.

$286.36M
As of 2025-12-31
$292.67M
As of 2026-06-30
+11.1%
3-year compound annual growth
-1.8%
5-year compound annual growth
$314.08M2020-12-31: $314.08M2021-12-31: $256.42M2022-12-31: $208.59M2023-12-31: $216.89M2024-12-31: $254.16M2025-12-31: $286.36M$286.36M
2020-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$286.36M+12.7%2026-02-26, Balance as of period end
2024-12-31$254.16M+17.2%2026-02-26, Balance as of period end
2023-12-31$216.89M+4.0%2025-02-27, Balance as of period end
2022-12-31$208.59M-18.7%2024-02-29, Balance as of period end
2021-12-31$256.42M-18.4%2023-02-28, Balance as of period end
2020-12-31$314.08Mn/a2022-03-18, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Ophthalmic Goods), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Warby Parker Inc. (WRBY)2025-12-31$286.36M+12.7%
National Vision Holdings, Inc. (EYE)2026-01-03$38.71M-47.7%
Staar Surgical Co (STAA)2026-01-02$153.15M+6.2%
Cooper Companies, Inc. (COO)2025-10-31$110.60M+2.8%
Bausch & Lomb Corp (BLCO)2025-12-31$383.00M+25.6%
RxSight, Inc. (RXST)2025-12-31$19.95M+19.4%
Innovative Eyewear Inc (LUCY)2025-12-31$6.51M+147.7%

Compare WRBY, EYE, STAA, COO side by side · Screen every company in Ophthalmic Goods ↗